Drug Shortage Report for OCTREOTIDE ACETATE OMEGA

Last updated on 2022-12-15 History
Report ID 172459
Drug Identification Number 02248639
Brand name OCTREOTIDE ACETATE OMEGA
Common or Proper name Octreotide Acetate Injection 50 MCG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) OCTREOTIDE
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5 x 1mL vial / fiole
ATC code H01CB
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-24
Estimated end date
Actual end date 2022-12-14
Shortage status Resolved
Updated date 2022-12-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-12-15 English Compare
v9 2022-12-14 French Compare
v8 2022-12-14 English Compare
v7 2022-12-02 French Compare
v6 2022-12-02 English Compare
v5 2022-11-04 French Compare
v4 2022-11-04 English Compare
v3 2022-10-25 English Compare
v2 2022-10-24 French Compare
v1 2022-10-24 English Compare

Showing 1 to 10 of 10